Norges Bank’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
Other funds holding KYMR
BBA
Norges Bank's KYMR Position: Q3 2026 in Review
Norges Bank sold out of Kymera Therapeutics (KYMR) in Q3 2026, closing a stake of 757,246 shares — an estimated $86.8M sold.
Norges Bank first reported a position in KYMR in Q3 2020 and held it in 23 quarters. The position peaked at $86.8M in Q2 2026. 301 funds tracked by Wall St. Rank hold KYMR as of Q3 2026.
- Norges Bank reported no remaining Kymera Therapeutics position as of Q3 2026 after selling out during the quarter.
- Norges Bank sold 757,246 Kymera Therapeutics shares in Q3 2026, an estimated $86.8M.
- Norges Bank first reported a position in Kymera Therapeutics in Q3 2020 and held it in 23 quarters.
- Norges Bank's Kymera Therapeutics position peaked at $86.8M in Q2 2026.
- 301 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q3 2026.
Based on Norges Bank's 13F filing for Q3 2026.